Skip to main content
OpenTrials

Clinical trial condition

Gonadal Disorders

Explore clinical trials studying Gonadal Disorders. Study availability and eligibility vary by location and protocol.

4,160 public trials 780 recruiting studies
Refine in advanced search Browse all conditions

Gonadal Disorders trial results

Completed

BI 6727 (Volasertib) Randomised Trial in Ovarian Cancer

NCT01121406

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • 1230.18.32003 Boehringer Ingelheim Investigational Site Brussels, Belgium
  • 1230.18.32004 Boehringer Ingelheim Investigational Site Edegem, Belgium
  • 1230.18.32002 Boehringer Ingelheim Investigational Site Ghent, Belgium
  • 1230.18.32001 Boehringer Ingelheim Investigational Site Leuven, Belgium
View all 31 locations
View Trial Details
Completed

Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer

NCT00003636

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Hospital de Clinicas "Jose De San Martin" Buenos Aires, Argentina
  • Shaare Zedek Medical Center Buenos Aires, Argentina
  • Karl-Franzens-University Graz Graz, Austria
  • Innsbruck Universitaetsklinik Innsbruck, Austria
View all 65 locations
View Trial Details
Completed

A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment

NCT00421889

Conditions
Adnexal Diseases, Bladder Cancer, Carcinoma, +27 more
Locations
  • Gynecologic Oncology Associates Newport Beach, California, United States
  • Research Facility Orlando, Florida, United States
  • Hematology and Oncology Specialists, LLC Covington, Louisiana, United States
  • Hematology & Oncology Specialists, LLC Metairie, Louisiana, United States
View Trial Details
Completed

UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

NCT00072267

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada
  • Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada
  • Ottawa Regional Cancer Centre Ottawa, Ontario, Canada
  • Princess Margaret Hospital Toronto, Ontario, Canada
View Trial Details
Completed

Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma

NCT00413075

Conditions
Adenoma, Adenosarcoma, Adnexal Diseases, +89 more
Locations
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • Columbia University - Herbert Irving Cancer Center New York, United States
  • New York University Cancer Institute New York, United States
  • M.D. Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions